(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

M MEDERMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

M MEDERMA

ST13

US500000079403136

Class

3, 5

Filing

79403136

Registration

7691628

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

04/03/2026

Trademark type

Combined

Nice classes

3, 5

Filing date

07/09/2024

Registration date

02/18/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/18/2025

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

FR

Examiner

QUILICI, BRENDAN A

Law office

N50

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of a first turquoise stripe, a second larger purple stripe with the word "MEDERMA" in white and a third grey stripe. Between the 1st and 2nd stripes, a stylized "M" made up of a chevron and triangles is in grey and brown and between the 2nd and 3rd stripes is a brown rectangle with the left side curved. Inside the rectangle is a purple semicircle and a stylized "M" made up of a chevron and triangles in white, purple, and brown.

Holders and representatives

Holders

Laboratoire HRA Pharma SAS

Representatives

Tamar Niv Bessinger Fross Zelnick Lehrman & Zissu, P.C.

Technical classification

Nice Classes

Class 3Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

Non-medicated cosmetics for skina gelcreamointment for improving the appearance of stretch marks or other skin imperfections.

Class 5

Pharmaceuticalsa gelcream or ointment designed to improve the appearance of stretch marks or other skin imperfections.

Publications

History of USPTO decisions and trademark events.

26 publications found

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

02/12/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/27/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

01/27/2026

FINV

FINAL DECISION TRANSACTION PROCESSED BY IB

09/19/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/02/2025

FIMP

FINAL DISPOSITION PROCESSED

09/02/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/20/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/18/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

02/18/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/03/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/31/2024

PUBO

PUBLISHED FOR OPPOSITION

12/31/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/25/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/06/2024

RFNT

REFUSAL PROCESSED BY IB

11/30/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/25/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/25/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/25/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/13/2024

RFRR

REFUSAL PROCESSED BY MPU

11/13/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/07/2024

CNRT

NON-FINAL ACTION WRITTEN

11/06/2024

DOCK

ASSIGNED TO EXAMINER

10/29/2024

MAFR

APPLICATION FILING RECEIPT MAILED

10/16/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/16/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/29/2024

Continuous trademark protection

Get notified about every new filing that threatens M MEDERMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.